Further, while HIF1A acts as a tumor suppressor, HIF2A promotes oncogenic potential by driving tumor progression and metastasis through activation of hypoxia-sensitive signaling pathways and overexpression of HIF2A target genes [18]. The gene discussed is HIF1A; the disease is neoplasm.